|
|
Vaso Active Pharmaceuticals Securities Litigation: Summary Notice of Proposed Settlement of Class Action and Derivative Action and Settlement Hearings
26 October 2005SUMMARY NOTICE OF PROPOSED SETTLEMENT OF CLASS ACTION AND DERIVATIVE ACTION
AND SETTLEMENT HEARINGS
TO: (i) ALL PERSONS AND ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED VASO CLASS A COMMON STOCK ON THE OPEN MARKET DURING THE PERIOD DECEMBER 9, 2003, THROUGH MARCH 31, 2004 (THE "CLASS PERIOD"); AND (ii) ALL PERSONS AND ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED SHARES OF VASO CLASS A COMMON STOCK IN CONNECTION WITH THE COMPANY'S INITIAL PUBLIC OFFERING ON OR ABOUT DECEMBER 9, 2003 (THE "IPO"); AND (ii) ALL CURRENT SHAREHOLDERS OF VASO CLASS A COMMON STOCK.
YOU ARE HEREBY NOTIFIED that pursuant to Court order, two hearings will be held. At the hearing for the Securities Settlement on December 14, 2005, at 3:00 p.m., before the United States District Judge Reginald C. Lindsey, at the United States Courthouse, 1 Courthouse Way, Room 2300, Boston, Massachusetts, the Court will determine: (1) whether the settlement of claims in the Securities Action in the amount of One Million One Hundred Twenty-Five Thousand Dollars ($1,125,000) in cash, plus Seven Hundred Fifty Thousand Dollars ($750,000) face amount of two year 5% subordinated callable notes convertible at $1.75 per share (with full dilution protection), plus accrued interest (collectively, the "Settlement Fund"), should be approved as fair, reasonable and adequate to all the Settling Parties; (2) whether the proposed Plan of Allocation is fair, reasonable and adequate; (3) whether the Securities Action should be dismissed with prejudice as set forth in the Stipulation and Agreement of Settlement dated September 21, 2005, and filed with the Court; and (4) whether the application of Lead Counsel in the Securities Action for an award of attorneys' fees and expenses should be approved.
At the hearing for the Derivative Settlement on December 14, 2005, at 3:00 p.m., before the United States District Judge Reginald C. Lindsey, at the United States Courthouse, 1 Courthouse Way, Room 2300, Boston, Massachusetts, the Court will determine: (1) whether the corporate governance remedies as proposed in the settlement of the Derivative Action are fair, reasonable and adequate; (2) whether a Final Judgment approving the proposed Settlement in the Derivative Action should be entered; and (3) whether the application of Derivative Counsel in the Derivative Action for an award of attorneys' fees and expenses should be approved.
IF YOU ARE A MEMBER OF THE CLASS DESCRIBED ABOVE, YOUR RIGHTS WILL BE AFFECTED AND YOU MAY BE ENTITLED TO SHARE IN THE SETTLEMENT FUND. If you are a Class Member, or a current shareholder, and have not yet received: (i) the full printed Joint Notice of Proposed Settlement of Class Action and Derivative Action, Application for Attorneys' Fees and Expenses, and Settlement Fairness Hearings; and (ii) a Proof of Claim and Release form, you may obtain copies of these documents by identifying yourself as a Class Member and/or a current shareholder and by contacting:
Vaso Active Pharmaceuticals Securities Litigation Claims Administrator c/o A.B. Data, Ltd. P. O. Box 170200 Milwaukee, WI 53217 www.abdatalawserve.com
Inquiries, other than requests for Notice forms or Proof of Claim and Release forms, may be made to:
Lead Counsel in the Securities: OR Plaintiffs' Counsel in the Action Derivative Action: Kay E. Sickles, Esq. Douglas S. Johnston, Jr., Esq. Schiffrin & Barroway, LLP Timothy L. Miles, Esq. 280 King of Prussia Road Barrett, Johnston & Parsley Radnor, PA 19087 217 Second Avenue North. Nashville, TN 37201
To participate in the Settlement in the Securities Action, you must submit a Proof of Claim and Release form no later than November 30, 2005. If you are a Class Member and do not exclude yourself from the Class, you will be bound by the Final Order and Judgment of the Court. To exclude yourself from the Class, you must submit a request for exclusion postmarked no later than November 30, 2005. If you are a Class Member and do not submit a proper Proof of Claim and Release form, you will not share in the Settlement in the Securities Action, but you nevertheless will be bound by the Final Order and Judgment of the Court.
Any inquiries about the Securities Action can be made in writing to Lead Counsel, at the addresses indicated above.
DO NOT TELEPHONE EITHER THE COURT, THE CLERKS' OFFICES OR ANY REPRESENTATIVE OF VASO REGARDING THIS NOTICE.
DATED: OCTOBER 4, 2005 BY ORDER OF THE UNITED STATES DISTRICT COURT,
DISTRICT OF MASSACHUSETTS
Source: PR Newswire
All trademarks and copyrighted information contained herein are the property of their respective owners.
Related Articles
- Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Pixar -- PIXR
25 October 2005
- Zwerling, Schachter & Zwerling, LLP Announces Filing of an Expanded Class Period for The Securities Class Action
23 October 2005
- Allos Therapeutics Announces Dismissal of Securities Class Action Lawsuit
22 October 2005
- Spector, Roseman & Kodroff, P.C. Announces the Filing of a Class Action Suit Against Dana Corporation -- DCN
22 October 2005
- Darryl M. Burman: Corporate and Securities Attorney Joins Epstein Becker Green Wickliff & Hall
21 October 2005
- Notice to All Microsoft Employees With Smith Barney Accounts at the Seattle Branch Offices From the Securities Arbitration Law Firm of Klayman & T
21 October 2005
- DHB Industries, Inc. Shareholders File Class Action Lawsuit
21 October 2005
- Securities Fraud Case First Filed By Scott + Scott, LLC Against Guidant Gives Market a Shock Because Of Faulty Defibrillators/ J & J Deal
21 October 2005
- Endo Pharmaceuticals Reports Third Quarter 2005 Financial Results
20 October 2005
- Shareholder Class Action Filed on Behalf of Shareholders of Refco, Inc. by the Law Firm of Schiffrin & Barroway, LLP
20 October 2005
- Nationwide Class Action Filed Against UBS Financial Services, Inc. Alleging a Company-wide Practice of Racial Discrimination
19 October 2005
- Humana Settles Physicians' Class Action
19 October 2005
- Notice of Filing Securities Class Action Against Immucor, Inc. and Certain of Its Former and Current Officers
18 October 2005
- Notice to All Current and Former Peter Kiewit Sons', Inc. Employees With Concentrated Positions in Level 3 Communications, Inc. From the Securities Ar
18 October 2005
- Wolf Popper LLP Files Securities Fraud Class Action Against Tag-It Pacific, Inc.
17 October 2005
|
|
|